Comparison of the Postoperative Use of Dextenza vs a Standard Regimen After PRK
NCT05587231
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
60
Enrollment
FED
Sponsor class
Conditions
Steroid Ophthalmic Insert
Interventions
DRUG:
Dextenza 0.4Mg Ophthalmic Insert
DRUG:
Topical Fluorometholone
Sponsor
Navy Medical Center San Diego